Federica Carloni

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
BACKGROUND To assess the role of the novel second-line treatments in nonsmall cell lung cancer (NSCLC). METHODS A systematic review of the literature with meta-analysis of phase III randomized(More)